A suite of best-practice tools developed by GeneEQUAL will support health professionals to provide inclusive, person-centred and respectful genetic health care for people with intellectual disability.

The impact of Australia’s national initiative to accelerate the use of genomics in mainstream healthcare has been captured in a report published in the American Journal of Human Genetics.

The ethical issues surrounding genomic testing are often complex and varied. A Question of Ethics is a four-part blog series by Australian Genomics, in collaboration with the Biomedical Ethics Research Group at the Murdoch Children’s Research Institute.

Front Line Genomics interviewed Felicity Boardman, Professor of Social Science in Genomics at Warwick University in the UK, who aims to bring lived experience perspectives to reproductive genetic technology.

The involvement of community members in the actual process and design of health research would be much more prevalent if people were aware they could do it, an Australian Genomics…

In a world-first, Monash University is leading a DNA screening program that will allow Australians aged 18-40 to assess their risk of cancer and heart disease. It is thought that early detection of these diseases will allow young Australians to make more informed health decisions.

CTRL is a convenient, web-based tool created by Australian Genomics which gives research participants more control over their consent preferences when involved in a study. Read more about CTRL and the principles of dynamic consent here.

Rapid genomic testing is transforming medical care – particularly the diagnosis of people with rare conditions. For some critically ill children, rapid genomic testing can even be lifesaving.

Queensland Genomics have produced a Genomics Information Toolkit for patients and families affected by rare disease. Information provided includes: what genomics is,
how it might help you or your family, where Queenslanders can get testing and the different kinds of genetic tests that are available.